Insider tradingForm 4
Royalty Pharma plc (RPRX) Insider Trading
5 open-market trades reported since Aug 17, 2026: 0 purchases worth $0 and 5 sales worth $13.0M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Marshall Urist | EVP | 0 | $0 | 2 | $474K |
| Christopher Hite | Chair | 0 | $0 | 2 | $11.9M |
| Terrance P. Coyne | CFO | 0 | $0 | 1 | $646K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 5 | Marshall UristEVP | ▼ SELL10b5-1 | $236K | |
| Sep 30 | Marshall UristEVP | ▼ SELL10b5-1 | $239K | |
| Sep 24 | Christopher HiteChair | ▼ SELL10b5-1 | $5.85M | |
| Aug 19 | Christopher HiteChair | ▼ SELL10b5-1 | $6.00M | |
| Aug 17 | Terrance P. CoyneCFO | ▼ SELL10b5-1 | $646K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings